22 May, 2020

Free Webinar: Drawing NGS Plasma at Time of Lung Biopsy

  CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]

21 Apr, 2020

Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology

 Cell-Free DNA Concentration Associated with Injury Severity and Survival  in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology   cfDNA levels correlate significantly with biomarkers of multiorgan damage in first abstract stemming from DOD research grant to [...]

17 Mar, 2020

CIRCULOGENE’s response to COVID-19

Dear All – I want to start this by saying Thank You! to all of our clients and staff members.  Each day – with your efforts – you help hundreds of patients by giving them [...]

17 Jun, 2019

CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury

$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel. BIRMINGHAM, Ala.--(BUSINESS [...]

25 Mar, 2019

CIRCULOGENE’s Precision Genomic Profiling Technology Featured in Three AACR 2019 Abstracts

Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing BIRMINGHAM, Ala.--(BUSINESS WIRE)-- CIRCULOGENE, advancing precision medicine through personalized [...]

19 Feb, 2019

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through molecular genetics testing, has named Anthony L. Schmidt, M.D., F.A.C.P., as Medical Director. Dr. Schmidt will lead the [...]

13 Feb, 2019

CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation

 BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its molecular diagnostics laboratory has received College of American Pathologists (CAP) accreditation based on a recent on-site inspection as part [...]

4 May, 2018

CIRCULOGENE’s PD-L1 Expression Test Featured in Clinical Lab Products Magazine

In the latest feature from Clinical Lab Products magazine, experts from First Health, Banner Health and Biodesix Inc. discuss progress and challenges on the way to a blood-based assay for PD-L1. The article, "Overcoming Immune Blockade in [...]

3 May, 2018

The Evolution of In Situ Genetic Technology

This review presents a perspective of in situ genetic technology, including a summary of the methods, principles, endpoints, and applications. The class of in situ genetic techniques has been used for direct measurement of gene functions in specific cell [...]

6 Feb, 2018

Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection

Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection Open Acc J Oncol Med 2018. Abstract  Somatic mutations have been perceived as the causal event in the origin of the vast majority of cancers. Advanced massively [...]